Order Article Reprints

Mokhtari S, Asquith JM, Kareem SS, Bachmeier CA, Pina Y, Faramand RG, Kim Y, Peguero EN, Sahebjam S, Jaffer MH, et al. Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy. International Journal of Molecular Sciences. 2025; 26(8):3904. https://doi.org/10.3390/ijms26083904

Mokhtari, Sepideh, Justin M. Asquith, Syeda Saba Kareem, Christina A. Bachmeier, Yolanda Pina, Rawan G. Faramand, Youngchul Kim, Edwin N. Peguero, Solmaz Sahebjam, Mohammad H. Jaffer, and et al. 2025. "Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy" International Journal of Molecular Sciences 26, no. 8: 3904. https://doi.org/10.3390/ijms26083904

Mokhtari, S., Asquith, J. M., Kareem, S. S., Bachmeier, C. A., Pina, Y., Faramand, R. G., Kim, Y., Peguero, E. N., Sahebjam, S., Jaffer, M. H., Iacono, D. P., Jain, M. D., Vogelbaum, M. A., Davila, M. L., Forsyth, P. A., Locke, F. L., & Lazaryan, A. (2025). Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy. International Journal of Molecular Sciences, 26(8), 3904. https://doi.org/10.3390/ijms26083904